Carlos Quezada Ruiz, MD

Carlos Quezada-Ruiz, M.D. is an active clinician with 10+ years of clinical and early to late stage research experience. Currently a Group Medical Director on Genentech’s Ophthalmology Clinical Science team and a practicing retina specialist in Monterrey, Mexico. Carlos’ current work focuses on the advancement of new and better therapies for patients afflicted with retinal diseases around the world, including being the Clinical Science Team Leader for the Port Delivery System (SUSVIMO) responsible for the Global Clinical Development Program of Susvimo in patients with nAMD, DR and DME. In the past, Carlos also led the Global Clinical Development Roche and Genentech’s Vabysmo (faricimab), Lucentis mCNV and PFS approvals as well as gene therapy and machine learning projects.

Carlos is Retina Surgeon and a board-certified ophthalmologist by the ECFMG (Educational Commission for Foreign Medical Graduates), the International Council of Ophthalmology and the Mexican Council of Ophthalmology and specializes in the treatment of medical and surgical retinal diseases such as diabetic retinopathy, retinal vein occlusion, retinal detachment and AMD.

Carlos has authored several peer-reviewed publications and book chapters and served as a peer reviewer and editorial board member for several Ophthalmology journals focusing on retinal diseases. He is a member of the Mexican Society of Ophthalmology, the Pan-American Association of Ophthalmology, the American Academy of Ophthalmology (AAO), the Association for Research in Vision and Ophthalmology (ARVO), the Mexican Retina Society and the American Society of Retina Specialists (ASRS). He was honored as the 2013 CONACYT fellow abroad, the Gillingham Pan-American Fellow and was granted the 2013 Leonard Ellen Ocular Pathology Fellowship award, 2016 ASRS Honor Award and the 2019 ASRS Senior Honor Award.

Carlos received his medical degree from the Autonomous University of Coahuila and completed his residency in Ophthalmology and Vitreoretinal Surgery Fellowship at the Instituto de Oftalmologia Fundacion “Conde de Valenciana” in Mexico City. He then completed an Ocular Pathology Research Fellowship at McGill University in Montreal, Canada and a research fellowship in retinal diseases and vitreoretinal surgery with the California Retina Consultants and Research Foundation in Santa Barbara, CA.